怀孕和产后抑郁期间使用抗生素或胃酸抑制剂:基于人口的队列研究
Unnur Gudnadottir1, Njeri Kamau2, Romina Fornes3
1Department of Microbiology Tumor and Cell Biology, center for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
Acta obstetricia et gynecologica Scandinavica
|June 4, 2024
概括
怀孕期间使用抗生素和胃酸抑制剂会增加产后抑郁风险. 这些常见的药物可能会影响母亲的心理健康,强调在产前护理期间需要仔细考虑.
科学领域:
- 围产期心理健康问题
- 药物监督 药物监督 药物监督
- 微生物组-肠-大脑轴研究
背景情况:
- 产后抑郁症 (PPD) 是一种影响新的非产科并发症.
- 肠道微生物和炎症都与PPD机制有关.
- 在怀孕期间调查药物效应对于母亲的健康至关重要.
研究的目的:
- 评估怀孕期间抗生素使用与患产后抑郁症的风险之间的关联.
- 评估在怀孕期间使用胃酸抑制剂对产后抑郁症风险的影响.
- 探索这些药物的剂量反应关系和PPD风险.
主要方法:
- 瑞典 (2006-2016) 基于人口的队列研究,包括第一个单子活产.
- 排除有抑郁病史的女性.
- 多变量逻辑回归分析以确定赔率比率 (OR) 和95%置信区间 (CI).
主要成果:
- 抗生素的使用与43%的PPD风险增加有关 (OR 1.43,95% CI 1.37-1.49).
- 胃酸抑制剂的使用与PPD风险的相关性更高 (OR2.04,95% CI 1.88-2.21).
- 两种药物类别都表明了剂量与反应的关系,增加了PPD风险.
结论:
- 在怀孕期间使用抗生素和胃酸抑制剂与产后抑郁症风险增加有关.
- 这些发现表明,这些药物与母亲心理健康结果之间存在潜在联系.
- 需要进一步的研究来了解混因素和因果关系.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
376
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
376
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
408
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
408
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
363
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
363
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
348
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
348
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
425
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
425


